H.-G. Schmalz et al.
FULL PAPER
(CH2Cl2/cyclohexane 2:3, Rf = 0.14) the product 6i (309 mg, 63%)
was obtained as a colorless oil (77% ee; determined by chiral GC),
(0.33 m, 9.5 mL, 13.15 mmol) of (4-vinylphenyl)magnesium brom-
ide in 2-Me-THF. After chromatography (EtOAc/cyclohexane 2:8;
Rf = 0.21) the product 6m (270 mg, 61%) was obtained as a yellow
oil (83% ee; determined by chiral HPLC). [α]λ (20 °C, CH2Cl2, c =
[α]λ (20 °C, CH2Cl2, c = 1.0 g/100 mL). [α]589 = +11.2 [α]546
=
+20.4, [α]405 = +138, [α]365 = +274, [α]334 = +119. CD (c =
0.56 mgmL–1 in CH3CN): Θ (γ) = +9.8 (292 nm). 1H NMR 1.05 g/100 mL): [α]589 = +1.5 [α]546 = +1.8 [α]405 = +15.1 [α]365
=
(600 MHz, CDCl3): δ = 1.69–1.77 (m, 1 H), 1.78–1.84 (m, 1 H), +39.1. CD (c = 0.52 mgmL–1 in CH3CN): Θ (γ) = +37.3 (297 nm).
2.04–2.06 (m, 1 H), 2.10–2.14 (m, 1 H), 2.41–2.44 (m, 1 H), 2.45–
2.50 (m, 1 H), 2.54–2.57 (m, 1 H), 2.89–2.94 (m, 1 H), 3.76 (s, 6
H), 6.32 (t, J = 2.4 Hz, 1 H), 6.35 (d, J = 2.3, 2 H) ppm. 13C NMR
(150 MHz, CDCl3): δ = 25.4, 32.5, 41.4, 44.9, 90.5, 91.1, 98.1,
1H NMR (600 MHz, CDCl3): δ = 1.72–1.86 (m, 2 H), 2.04–2.07
(m, 1 H), 2.12–2.15 (m, 1 H), 3.33–3.39 (m, 1 H), 2.43–2.46 (m, 1
H), 2.50–2.53 (m, 1 H), 2.55–2.59 (m, 1 H), 2.96–3.01 (m, 1 H),
5.52 (d, J = 11.3 Hz, 1 H), 5.72 (d, J = 17.1 Hz, 1 H), 6.70 (dd, J
104.7, 109.0, 111.8, 123.4, 126.4, 135.7, 135.8, 146.7, 160.9, = 17.7, 10. 9 Hz 1 H), 7.71 (d, J = 7.9 Hz, 2 H), 7.36 (d, J = 8.4 Hz,
210.8 ppm. IR (neat): ν = 2986 (w), 2935 (m), 2833 (w), 1706 (s),
2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 25.4, 32.7, 41.2, 44.4,
˜
1593 (s), 1457 (s), 1426 (s), 1353 (m), 1316 (s), 1260 (m), 1193 (s),
48.8, 113.6, 126.4, 126.7, 136.1, 136.3, 143.9, 210.9 ppm. IR (neat):
1148 (s), 1060 (s), 827 (s), 695 (s) cm–1. Retention times (6- ν = 2932 (m), 1706 (s), 1603 (w), 1502 (m), 1448 (s), 1439 (m),
˜
TBDMS-2,3-Me-β-CD, initial temp, 70 °C, rate 0.5 °C min–1, final
temp. 180 °C): 71.8 min (minor)/72.3 min (major). HRMS: calcd.
for C14H18O3 234.13; found 234.126.
1233 (s), 1033 (s) cm–1. Retention times (HPLC I, Merck–Hitachi,
hexane/propan-2-ol, 90:10, initial temp. r.t., flow: 1.00 mL min–1):
10.60 min (major)/15.2 min (minor). HRMS: calcd. for C14H16O
200.1201; found 200.120.
(R)-3-(3,4-Methylenedioxyphenyl)cyclohexanone (6k): As described
in the General Procedure, a solution of CuBr·SMe2 (17.3 mg,
0.084 mmol), ligand 4b (111 mg, 0.126 mmol), and cyclohex-2-en-
one (5, 0.20 mL, 2.1 mmol) in 2-Me-THF (7 mL) was treated with
a solution (0.45 m, 7 mL, 3.15 mmol) of [3,4-(methylenedioxy)-
phenyl]magnesium bromide in 2-Me-THF. After chromatography
(EtOAc/cyclohexane 1:9, Rf = 0.22) the product 6k (304 mg, 69%)
was obtained as a yellow oil (65% ee; determined by chiral GC).
Supporting Information (see footnote on the first page of this arti-
1
cle): Copies of H and 13C NMR spectra and chromatograms (ee
analysis) for compounds 6a, 6b, 6c, 6d, 6g, 6h, 6j, 6k, and 6l.
Acknowledgments
This work was carried out in the context of COST D40. We would
like to gratefully acknowledge the Deutscher Akademischer Aus-
tauschdienst (DAAD) for a PhD scholarship award to Q. N. We
also would like to thank Chemetall GmbH, Frankfurt/Main, for
generous gifts of Grignard reagents, Andreas Adler for HPLC mea-
surements, and Dr. Tobias Robert for valuable discussions and ad-
vice.
[α]λ (20 °C, CH2Cl2, c = 0.825 g/100 mL): [α]589 = –10.6 [α]546
=
–10.6. CD (c = 0.62 mgmL–1 in CH3CN): Θ (γ) = +14.46 (290 nm).
1H NMR (600 MHz, CDCl3): δ = 1.69–1.80 (m, 2 H), 2.01–2.04
(m, 1 H), 2.09–2.13 (m, 1 H), 2.31–2.36 (m, 1 H), 2.41–2.46 (m, 2
H), 2.52–2.55 (m, 1 H), 2.88–2.93 (m, 1 H), 5.91 (s, 2 H), 6.64 (dd,
J = 8.0, 1.5 Hz, 1 H), 6.70 (d, J = 1.4 Hz, 1 H), 6.74 (d, J = 8.0 Hz,
1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 25.4, 33.0, 41.1, 44.5,
49.3, 100.9, 107.0, 108.3, 119.4, 138.4, 146.1, 147.8, 210.9 ppm. IR
(neat): ν = 2932 (w), 1706 (s), 1603 (w), 1502 (m), 1484 (s), 1033
˜
[1] For reviews on asymmetric 1,4-additions in general, see: a) H.-
G. Schmalz, in: Comprehensive Organic Synthesis, vol. 4 (Eds.:
B. M. Trost, I. Fleming), Pergamon, Oxford, 1991, pp. 199–
236; b) B. E. Rossiter, N. M. Swingle, Chem. Rev. 1992, 92,
771–806; c) N. Krause, A. Hoffmann-Röder, Synthesis 2001,
171–196; d) J. Christoffers, G. Koripelly, A. Rosiak, M. Rössle,
Synthesis 2007, 1279–1300.
[2] For reviews on Cu-catalyzed enantioselective 1,4-additions, see:
a) F. López, A. J. Minaard, B. L. Feringa, Acc. Chem. Res.
2007, 40, 179–188; b) M. S. Harutyunyan, T. den Hartog, K.
Geurts, A. J. Minnard, B. L. Feringa, Chem. Rev. 2008, 108,
2824–2852; c) A. Alexakis, J. E. Bäckvall, N. Krause, O. Pam-
ies, M. Dieguez, Chem. Rev. 2008, 108, 2796–2823; d) T. Jer-
phagnon, M. G. Pizzuti, A. J. Minnaard, B. L. Feringa, Chem.
Soc. Rev. 2009, 38, 1039–1075; e) T. Thaler, P. Knochel, Angew.
Chem. 2009, 121, 655–658; Angew. Chem. Int. Ed. 2009, 48,
645–648.
[3] For selected publications, see: a) B. L. Feringa, Acc. Chem. Res.
2000, 33, 346–353; b) I. H. Escher, A. Pfaltz, Tetrahedron 2000,
56, 2879–2888; c) S. J. Degrado, H. Mizutani, A. H. Hoveyda,
J. Am. Chem. Soc. 2001, 123, 755–756; d) M. T. Reetz, A. Gos-
berg, D. Moulin, Tetrahedron Lett. 2002, 43, 1189–1191; e)
P. K. Fraser, S. Woodward, Chem. Eur. J. 2003, 9, 776–783; f)
A. Alexakis, V. Albrow, K. Biswas, M. d’Augustin, O. Prietob,
S. Woodward, Chem. Commun. 2005, 2843–2845; g) L. Su, X.
Li, W. L. Chan, X. Jia, A. S. C. Chan, Tetrahedron: Asymmetry
2003, 14, 1865–1869; for a review on the use of Al-organyls
see: h) P. von Zezschwitz, Synthesis 2008, 1809–1831.
(s) cm–1. Retention times (BGB 176 SE, initial temp. 40 °C, rate
0.2 °C min–1, final temp. 170 °C): 71.8 min (minor)/72.3 min
(major). HRMS: calcd. for C13H16O3 218.094; found 218.095.
(R)-3-(2-Naphthyl)cyclohexanone (6l): As described in the General
Procedure, a solution of CuBr·SMe2 (17.3 mg, 0.084 mmol), ligand
4b (111 mg 0.126 mmol), and cyclohex-2-enone (5, 0.20 mL,
2.1 mmol) in 2-Me-THF (7 mL) was treated with a solution
(0.56 m, 5.6 mL, 3.15 mmol) of 2-naphthylmagnesium bromide in
2-Me-THF. After chromatography (EtOAc/cyclohexane 1:9; Rf =
0.28) the product 6l (306 mg, 68%) was obtained as a white solid
(65% ee; determined by chiral HPLC), [α]λ (20 °C, CH2Cl2, c =
0.98 g/100 mL): [α]589 = +6.5 [α]546 = +6.6 [α]405 = +93.5 [α]365
=
+254. CD (c = 0.63 mgmL–1 in CH3CN): Θ (γ) = +40.6 (292 nm).
1H NMR (600 MHz, CDCl3): δ = 1.77–1.86 (m, 1 H), 1.91–1.99
(m, 1 H), 2.14–2.20 (m, 1 H), 2.38–2.44 (m, 1 H), 2.46–2.41 (m, 1
H), 2.60–2.69 (m, 2 H), 3.14–3.20 (m, 1 H), 7.34–7.36 (d, J =
8.3 Hz, 1 H), 7.41–7.48 (m, 2 H), 7.63 (s, 1 H), 7.72–7.71 (m, 3
H) ppm. 13C NMR (150 MHz, CDCl3): δ = 25.5, 32.6, 41.2, 44.7
48.8, 124.7, 125.6, 126.1, 127.6, 128.3, 132.3, 133.4, 141.6, 210.9
(s) ppm. IR (neat): ν = 3040 (w), 2930 (w), 2860 (w), 1703 (s), 1630
˜
(w), 1259 (m), 1220 (m), 1017 (m), 813 (s), 745 (s) cm–1. Retention
times (HPLC I, Merck–Hitachi, hexane/propan-2-ol, 99:01, initial
temp. r.t., flow: 1.00 mL min–1): 27.32 min (minor)/31.47 min
(major, R). HRMS: calcd. for C16H16O 224.1201; found 224.120.
[4] a) K.-H. Ahn, R. B. Klassen, S. J. Lippard, Organometallics
1990, 9, 3178–3181; b) D. M. Knotter, F. Lambert, M.
van Klaveren, M. D. Janssen, G. Van Koten, Tetrahedron:
Asymmetry 1991, 2, 1097–1100; c) M. Spescha, G. Rihs, Helv.
Chim. Acta 1993, 76, 1219–1230; d) Q.-L. Zhou, A. Pfaltz, Tet-
(R)-3-(4-Vinylphenyl)cyclohexanone (6m): As described in the Gene-
ral Procedure, a solution of CuBr·SMe2 (17.3 mg, 0.084 mmol), li-
gand 4b (111 mg, 0.126 mmol), and cyclohex-2-enone (5, 0.20 mL,
2.1 mmol) in 2-Me-THF (7 mL) was treated with a solution
1184
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 1179–1185